期刊文献+

1-(2,3-二氯苯基)哌嗪的合成及其工艺研究

Research on the preparation method of 1-(2,3-(dichloro-)phenyl)piperazine
下载PDF
导出
摘要 1-(2,3-二氯苯基)哌嗪是一种重要的医药中间体,本文采用了两条合成路线,一是以2,6-二氯硝基苯和无水哌嗪为原料,经过烃化、乙酰化、硝基还原、桑德迈尔反应及水解等过程,将硝基转变为氯原子合成该中间体;二是直接用无水哌嗪与2,3-二氯溴苯通过乌尔曼反应合成。第一条路线的总收率以及产品质量都优于第二条路线,其总收率为53.3%。讨论了各步反应的影响因素,最终产物的结构通过红外光谱、核磁共振光谱得到了表征。 1-(2,3-dichlorophenyl)piperazine is a kind of pharmaceutical intermediate. The paper described two synthetic ways. One was to react 2,6-dichloro-nitrobenzene with anhydrous piperazine and then change the nitryl group to chlorine by acidulation, reduction, Sandmeyer and hydrolysis. Another way was to combine directly anhydrous piperazine with 2, 3-dicldoro-bromobenzene through Ullmann reaction. The former was better in terms of the quality and quantity of the final product. The total yield was 53.3%. The factors which influence every single reaction were discussed. The structure of 1- (2,3-dichlorophenyl) piperazine was confirmed by IR and ^1HNMR.
作者 李宁蔚 朱泉
出处 《化学试剂》 CAS CSCD 北大核心 2006年第8期507-509,共3页 Chemical Reagents
关键词 1-(2 3-二氯苯基)哌嗪 医药中间体 合成 1- ( 2, 3-dichlorophenyl ) piperazine pharmaceutical intermediate preparation
  • 相关文献

参考文献5

  • 1EYAL M, CABMEN S D, TIMOTHY J M, et al. Formation of phenylpiperazines by a novel alumina supported bis-alkylation [J]. Tetrahedron Lett. , 1996,37 (3): 319-322.
  • 2MASAKAZU N,TOSHIHIDE Y,YASUYUKI K. Synthesis of n-arylpiperazines from aryl halides and piperazine under a palladium tri-tert-butylphosphine catalyst [J]. Tetrahedron Lett., 1998,39(7) :617-620.
  • 3童荣标,郭灿城.铜和硫酸铜选择性催化合成单取代苯基哌嗪的新方法[J].化学试剂,2003,25(4):239-240. 被引量:3
  • 4HEERES J,BACKX L J J,MOSTMANS J H,et al. Synthesis and antifungal activity of ketoconazole, a new potent orally active broad-spectrum antifungal agent[J].J. Med. Chem. , 1979,22(8) : 1003.
  • 5zICHAEL J R, STEPHEN M H,ANDRZEJ K, et al. Design and synthesis of [( 2, 3-diehlorophenyl ) piperazin-l-yl ] alkylfluorenylcarboxamides as novel ligands selective for the dopamine D3 receptor subtype[J]. J. Med. Chem. ,2001,44 (19) :3181-3182.

二级参考文献8

  • 1Broekkamp C L E, Leysen D B, Peeters W M M,et al.[J]. J. Med. Chem. , 1995, 38:4615-4633.
  • 2Fuller R W, Maso N R, Molloy B B. [J]. Biochem. Pharmacol. , 1980,29:833-835.
  • 3Hagihara M, Kashiwase H, et al. [J]. Bioorganic & Medicinal Chemistry Letters, 1999,9 : 3063-3068.
  • 4Mishani E,Dence C S. [J]. Tetrahedron Lett., 1996,37:319-322.
  • 5Hoeve W T,Kruse C S, McCarthy T J,et al. [J]. J.Org. Chem. , 1993, 58:5101-5106.
  • 6Zhao Shuhai,Miller A K, Berger J,et al. [J]. Tetra-hedron Lett., 1996, 37: 4463-4466.
  • 7Nishiyama M, Yamamoto T, Koie Y. [J]. Tetrahedron Lett., 1998, 39:617-620.
  • 8Glennon R A. [J].J. Med. Chem. , 1987, 30:930-932.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部